COVAXIN
Delhi Received Over 60,000 Covaxin Doses for 45-Plus Age Group and Key Workers, Says AAP MLA Atishi
COVID-19 Vaccine Update: COVAXIN Phase II/III Clinical Trails in Age Group of 2 to 18 Years to Begin in 10-12 Days
Gujarat Govt in Talks With Bharat Biotech To Ramp Up Production of Covaxin, Says Department of Biotechnology
Covaxin Manufacturing Plant of Bharat Biotech To Be Set Up in Kolar’s Malur Industrial Area, Says Karnataka Deputy CM Dr CN Ashwathnarayan
COVID-19 Vaccine Update: Hyderabad's Bharat Biotech to Start Producing Coronavirus Vaccines in Pune
Covid-19 Vaccine Shortage: Karnataka & Maharashtra Stop Vaccinating 18 To 44 Year Olds, Delhi To Only Give Covishield
50 Employees of Bharat Biotech Test COVID-19 Positive; Joint MD Suchitra Ella's Tweet Draws Bouquets and Brickbats
COVAXIN Phase 2 and 3 Trials for 2 to 18 Age Group Approved by DCGI, Bharat Biotech To Conduct Trials on 525 Healthy Volunteers
COVID-19 Vaccine Shortage: Bharat Biotech Has Informed That It Can't Provide Additional Covaxin Doses to Delhi, Says Dy CM Manish Sisodia
Bharat Biotech's COVID-19 Vaccine Covaxin Recommended by Expert Panel for Phase 2/3 Trials on 2-18 Year-Olds
Delhi Has Run Out of COVAXIN Stock for 18–44 Age Group, Will Have To Shut 125 COVID-19 Vaccination Centres: AAP MLA Atishi
Maharashtra Govt Considering Holding Off COVID-19 Vaccination for 18–44 Age Group Due to Shortage of COVAXIN Doses, Says Health Minister Rajesh Tope
Delhi CM Arvind Kejriwal Writes To PM Narendra Modi, Requesting To Allow Other Companies To Manufacture COVID-19 Vaccines
COVID-19 Vaccination in India: Bharat Biotech Commences Direct Supply of ‘Covaxin’ to 14 States
Google Trends